Cargando…
Membranous nephropathy caused by dimercaptosuccinic acid in a patient with Wilson’s disease: a case report and literature review
BACKGROUND: Dimercaptosuccinic acid (DMSA) therapy is a kind of chelation therapy for patients with Wilson ‘s disease (WD). While there have been reports of side effects associated with DMSA, the development of membranous nephropathy as a result of this therapy is uncommon. CASE PRESENTATION: We pre...
Autores principales: | Li, Xiang, Hu, FengXin, Xu, Gaosi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224204/ https://www.ncbi.nlm.nih.gov/pubmed/37237412 http://dx.doi.org/10.1186/s12882-023-03201-6 |
Ejemplares similares
-
Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson’s disease patients with penicillamine-induced allergy or early neurological deterioration
por: Zhu, Xiao-Qun, et al.
Publicado: (2020) -
IgA Nephropathy with Wilson's Disease: A Case Report and Literature Review
por: Bhandari, Gaurav, et al.
Publicado: (2021) -
New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination
por: Ma, Qiqi, et al.
Publicado: (2022) -
Dimercaptosuccinic acid: A multifunctional cost effective agent for imaging and therapy
por: Shukla, Jaya, et al.
Publicado: (2015) -
Role of garlic extract and silymarin compared to dimercaptosuccinic acid (DMSA) in treatment of lead induced nephropathy in adult male albino rats
por: El-Khishin, Iman A., et al.
Publicado: (2015)